Arcellx Director Executes $94,740 Stock Sale Kavita Patel, a director at Arcellx, sold 1,500 shares worth $94,740 under a pre-arranged trading plan. Despite the sale, analysts maintain a strong buy consensus for the stock, citing promising clinical data and strategic collaborations that bolster its competitive position in the biotech market.2